Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8401-8450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05574036
Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia
PHASE2
Active, not recruiting
70 participants
Started: Aug 25, 2022 · Completed: Dec 25, 2026
2 conditions
1 sponsor
1 location
NCT06259500
Patient-derived Stem Cell Models of Anorexia Nervosa
N/A
Active, not recruiting
20 participants
Started: Aug 25, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05240807
Clinical Impact of Cardiac Photon Counting CT
NA
Active, not recruiting
450 participants
Started: Aug 24, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05445323
Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
PHASE1/PHASE2
Active, not recruiting
8 participants
Started: Aug 24, 2022 · Completed: Sep 30, 2029
2 conditions
1 sponsor
3 locations
NCT05814159
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
PHASE3
Active, not recruiting
15 participants
Started: Aug 24, 2022 · Completed: Jun 24, 2026
2 conditions
2 sponsors
8 locations
NCT05430230
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
PHASE4
Active, not recruiting
20 participants
Started: Aug 24, 2022 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
NCT05509569
A Survey of Icatibant in Pediatric Participants with Hereditary Angioedema
N/A
Active, not recruiting
32 participants
Started: Aug 24, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05361395
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
PHASE1
Active, not recruiting
184 participants
Started: Aug 24, 2022 · Completed: Aug 28, 2028
1 condition
1 sponsor
44 locations
NCT04802161
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
PHASE2
Active, not recruiting
50 participants
Started: Aug 24, 2022 · Completed: Apr 25, 2026
6 conditions
1 sponsor
11 locations
NCT05397093
ITIL-306 in Advanced Solid Tumors
PHASE1
Active, not recruiting
51 participants
Started: Aug 24, 2022 · Completed: Nov 30, 2039
3 conditions
1 sponsor
2 locations
NCT05399888
A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
PHASE2
Active, not recruiting
416 participants
Started: Aug 24, 2022 · Completed: Jan 8, 2029
2 conditions
1 sponsor
138 locations
NCT05565586
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
NA
Active, not recruiting
31 participants
Started: Aug 23, 2022 · Completed: Jan 2, 2029
1 condition
1 sponsor
1 location
NCT05515575
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
PHASE2
Active, not recruiting
8 participants
Started: Aug 23, 2022 · Completed: Aug 31, 2026
2 conditions
2 sponsors
7 locations
NCT05536973
Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
PHASE2
Active, not recruiting
69 participants
Started: Aug 23, 2022 · Completed: Aug 31, 2028
1 condition
1 sponsor
39 locations
NCT04936685
Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers
PHASE3
Active, not recruiting
209 participants
Started: Aug 23, 2022 · Completed: Dec 26, 2027
2 conditions
1 sponsor
26 locations
NCT05515029
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis
PHASE3
Active, not recruiting
56 participants
Started: Aug 23, 2022 · Completed: Oct 16, 2026
6 conditions
1 sponsor
1 location
NCT05508984
Clinical Outcomes and Patient Satisfaction With Use of the Amma System
N/A
Active, not recruiting
15 participants
Started: Aug 22, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT05014776
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
PHASE2
Active, not recruiting
17 participants
Started: Aug 22, 2022 · Completed: Apr 3, 2026
1 condition
3 sponsors
1 location
NCT04752813
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PHASE2
Active, not recruiting
50 participants
Started: Aug 22, 2022 · Completed: Aug 26, 2030
2 conditions
1 sponsor
11 locations
NCT05561868
COVID-19 Antibody Responses in Cystic Fibrosis
N/A
Active, not recruiting
70 participants
Started: Aug 22, 2022 · Completed: Sep 1, 2025
2 conditions
4 sponsors
2 locations
NCT05345834
The DC Mother-Infant Behavioral Wellness Program
NA
Active, not recruiting
700 participants
Started: Aug 22, 2022 · Completed: Nov 30, 2026
3 conditions
3 sponsors
1 location
NCT05111509
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
EARLY_PHASE1
Active, not recruiting
20 participants
Started: Aug 22, 2022 · Completed: Jun 30, 2026
2 conditions
4 sponsors
1 location
NCT06091995
Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients with Delayed Graft Function
N/A
Active, not recruiting
300 participants
Started: Aug 22, 2022 · Completed: Aug 22, 2025
1 condition
1 sponsor
1 location
NCT05471076
Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV
PHASE1
Active, not recruiting
52 participants
Started: Aug 22, 2022 · Completed: May 21, 2026
1 condition
3 sponsors
6 locations
NCT05491161
The Motility Mother-Child Cohort
N/A
Active, not recruiting
250 participants
Started: Aug 22, 2022 · Completed: Jul 1, 2027
2 conditions
6 sponsors
1 location
NCT05487118
PBMT Associated With MCE for Chronic Non- Specific Low Back Pain
NA
Active, not recruiting
148 participants
Started: Aug 22, 2022 · Completed: Aug 31, 2026
1 condition
2 sponsors
2 locations
NCT06630156
The Present Study Was Conducted to Evaluate Bioceramic Root Repair Material Versus Bio MTA in Revascularization of Immature Young Permenant Teeth.
PHASE2
Active, not recruiting
28 participants
Started: Aug 21, 2022 · Completed: Dec 21, 2024
1 condition
1 sponsor
1 location
NCT07028645
Uroflowmetry and Nocturnal Enuresis
N/A
Active, not recruiting
100 participants
Started: Aug 20, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05500014
Effect of Altitude on Iron Absorption in Iron Depleted Women
NA
Active, not recruiting
80 participants
Started: Aug 20, 2022 · Completed: Apr 30, 2024
3 conditions
3 sponsors
2 locations
NCT05413018
An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
PHASE2
Active, not recruiting
78 participants
Started: Aug 19, 2022 · Completed: Mar 1, 2026
1 condition
1 sponsor
34 locations
NCT05414175
A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
PHASE3
Active, not recruiting
38 participants
Started: Aug 19, 2022 · Completed: Mar 6, 2026
1 condition
1 sponsor
20 locations
NCT05365230
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
PHASE4
Active, not recruiting
261 participants
Started: Aug 19, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05458128
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
PHASE3
Active, not recruiting
128 participants
Started: Aug 19, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
32 locations
NCT05516992
Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine
PHASE3
Active, not recruiting
417 participants
Started: Aug 19, 2022 · Completed: Aug 27, 2025
1 condition
2 sponsors
30 locations
NCT05466994
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)
PHASE2
Active, not recruiting
29 participants
Started: Aug 19, 2022 · Completed: Oct 31, 2026
2 conditions
2 sponsors
2 locations
NCT06559787
Volumetric Quantification of Epicardial Fat Using Semiautomated High Resolution Atrial CT Segmentation in Patients With Atrial Fibrillation Receiving Catheter Ablation
N/A
Active, not recruiting
200 participants
Started: Aug 18, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05314010
A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
PHASE3
Active, not recruiting
102 participants
Started: Aug 18, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT05507827
Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL
PHASE1
Active, not recruiting
22 participants
Started: Aug 18, 2022 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT05230004
Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth
NA
Active, not recruiting
28 participants
Started: Aug 18, 2022 · Completed: Dec 30, 2025
2 conditions
2 sponsors
1 location
NCT04646226
The Arteriovenous Vascular (AV) ACCESS Trial
NA
Active, not recruiting
103 participants
Started: Aug 18, 2022 · Completed: Aug 31, 2027
2 conditions
2 sponsors
7 locations
NCT04726787
RadiothErapy priMIng for CAR-T
NA
Active, not recruiting
6 participants
Started: Aug 18, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
3 locations
NCT05424822
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
PHASE1
Active, not recruiting
167 participants
Started: Aug 18, 2022 · Completed: Jul 30, 2027
2 conditions
1 sponsor
29 locations
NCT05361746
Scotchbond Universal Plus Compared to Scotchbond Universal With Filtek Universal Restorative to Restore Class V NCCLs
NA
Active, not recruiting
38 participants
Started: Aug 18, 2022 · Completed: Jul 30, 2025
1 condition
1 sponsor
1 location
NCT05253118
Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
PHASE2
Active, not recruiting
28 participants
Started: Aug 18, 2022 · Completed: Feb 28, 2026
1 condition
5 sponsors
1 location
NCT05121974
Tebipenem Trial in Children With Shigellosis
PHASE2
Active, not recruiting
132 participants
Started: Aug 18, 2022 · Completed: Aug 17, 2026
1 condition
4 sponsors
1 location
NCT05475691
Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America
N/A
Active, not recruiting
361 participants
Started: Aug 17, 2022 · Completed: Jan 30, 2025
1 condition
2 sponsors
18 locations
NCT05393934
Growth Faltering Intervention Using Pediatric Nutritional Care (PNC) vs.PNC& FSMP
NA
Active, not recruiting
188 participants
Started: Aug 17, 2022 · Completed: Dec 31, 2024
1 condition
4 sponsors
1 location
NCT05451810
A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma
PHASE2
Active, not recruiting
184 participants
Started: Aug 17, 2022 · Completed: Mar 31, 2027
2 conditions
2 sponsors
72 locations
NCT05342883
GammaTile and Stupp in Newly Diagnosed GBM
PHASE4
Active, not recruiting
61 participants
Started: Aug 17, 2022 · Completed: Dec 1, 2027
1 condition
1 sponsor
16 locations
NCT05327530
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
PHASE2
Active, not recruiting
256 participants
Started: Aug 17, 2022 · Completed: Jun 25, 2026
1 condition
2 sponsors
97 locations
Previous
1
More pages
166
167
168
169
170
171
172
More pages
431
Next